Esprinet (PRT) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
27 Dec, 2025Executive summary
H1 2025 sales reached €1,931.5M, up 4% year-over-year, with Q2 sales at €969.1M, up 5% from Q2 2024, and strong profitability driven by high-margin segments and cost optimization.
Adjusted EBITDA for H1 was €25.1M (+2% YoY), with Q2 EBITDA up 38% and net income at €3.4M (+5% YoY); Q2 net income rose to €2.9M from €54K in Q2 2024.
The Group outperformed the Italian market, with strong growth in Iberia and Portugal, and consolidated leadership in high-tech, digital transformation, and green tech segments.
Cost optimization and strict cost control supported operational efficiency, with ongoing focus on higher-margin businesses and rationalization of low-margin segments.
The European reference market grew faster than expected, with the Iberian Peninsula showing significant growth and Italy remaining flat year-over-year.
Financial highlights
Revenue: €1,931.5M (+4% YoY); Q2 revenue up 5% YoY; gross profit for H1 was €110.9M (+6% YoY), margin at 5.74%.
Adjusted EBITDA: €25.1M (+2% YoY); Q2 EBITDA up 38%; EBIT: €12.9M (-8% YoY) due to higher amortization from new warehouse.
Net result: €3.4M (+5% YoY); EPS stable at €0.07.
Net financial position was negative €327.5M, worsened from -€164.0M a year earlier, mainly due to new lease liabilities and working capital changes.
Cash conversion cycle increased to 29 days (+7 days YoY); factoring programs at €347M.
Outlook and guidance
2025 adjusted EBITDA expected between €63M and €71M, with optimism for the upper end of the range.
Revenue growth accelerated in July and August, especially in Iberia and Italy.
Focus remains on high-margin segments (V-Valley, Zeliatech) and ongoing cost optimization.
Industry analysts expect low- to mid-single-digit growth in the ICT distribution market for H2 2025, with Spain outperforming Italy.
Guidance remains cautious due to ongoing rationalization and macro/geopolitical uncertainties.
Latest events from Esprinet
- 5% sales growth, stable EBITDA, €0.35 dividend, and CEO transition planned for 2026.PRT
Q4 202513 Mar 2026 - Q2 2024 delivered 9% EBITDA growth, improved cash cycle, and market share gains in key segments.PRT
H1 202421 Jan 2026 - Q3 sales up 11% and margin resilience drive positive EBITDA guidance for 2024.PRT
Q3 202414 Jan 2026 - Robust 2024 growth, margin gains, and strategic expansion into digital and green tech.PRT
Q4 202417 Dec 2025 - Sales up 4% to €2.89bn, EBITDA Adj. up 3%, guidance confirmed at upper end of €63–71m.PRT
Q3 202526 Nov 2025 - Q1 sales up 4% to €962.4M, but EBITDA Adjusted down 24% on higher costs.PRT
Q1 202519 Nov 2025